Ohio State University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Ohio State University sits in the top decile of US sponsors by registered trial count (#66 of 15,742 sponsors by registered trial count).

552 total trials 117 currently recruiting 319 completed early-phase tilt top decile by trial count

Ohio State University: 552 sponsored US clinical trials, 117 recruiting.

Ohio State University sponsors 552 registered US clinical trials on ClinicalTrials.gov, 117 of them currently recruiting, and 319 completed. 39 of these trials are in Phase 3-4 (later-stage) and 60 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Suicidal Ideation, with 8 trials.

Top-decile sponsor footprint

Ohio State University ranks in the top decile of sponsors by registered trial count (#66 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 57/100

319 of 366 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

552 total, page 10 of 12

COMPLETED Phase 1

Near Infrared Fluorescence Cholangiography (NIRF-C) During Cholecystectomy -- Use in Acute Cholecystitis Sub-Study

NCT02070627

COMPLETED

The Flashing Light-Induced Pupil Response (FLIPR) Glaucoma Study

NCT01857440

COMPLETED NA

Green Tea Confections For Managing Postprandial Hyperglycemia-Induced Vascular Endothelial Dysfunction

NCT01857258

COMPLETED NA

High Definition Neuromuscular Stimulation in Tetraplegia

NCT04075812

COMPLETED Phase 4

Testing the Anesthetic Effectiveness of Buffered Articaine Injected Next to a Lower First Molar.

NCT01862614

COMPLETED NA

Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome

NCT01787591

COMPLETED NA

Effect of Buffered Numbing Solution on Patients With Toothaches

NCT01868776

COMPLETED NA

Efficacy of Buffered Lidocaine in Patients With Facial Swelling

NCT01981772

COMPLETED

Nutrition Blood Outcomes Following Tocotrienol N2B

NCT01858311

COMPLETED NA

Effect of Root Canal Treatment (Versus no Treatment) for Patients With Tooth Infections and Toothaches

NCT01870973

TERMINATED Phase 4

Comparison of Actifuse ABX and Local Bone in Spinal Surgery

NCT01852747

COMPLETED NA

Outcomes of CPM Usage Following Arthroscopic Acetabular Labral Repair

NCT03407612

COMPLETED NA

Treadmill Walking in Individuals With Dementia With Lewy Bodies and Huntington's Disease

NCT02268617

COMPLETED NA

Near Infrared Fluorescence Cholangiography (NIRF-C) During Cholecystectomy

NCT02070640

COMPLETED NA

Testing Fish Oil Derivatives In Healing Of Chronic Venous Leg Ulcers

NCT01754506

COMPLETED

Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development

NCT01736553

COMPLETED NA

Evaluation of a Lifestyle Intervention for Employees With Prediabetes

NCT01682954

COMPLETED NA

Comparative Effectiveness of Stress Tests

NCT01875315

COMPLETED NA

Peroral Endoscopic Myotomy (POEM) for the Treatment of Achalasia

NCT02073578

COMPLETED NA

Pilot Study to Assess the Feasibility and Initial Efficacy of Therapist-as-consultant, Game-based CI Therapy

NCT03005457

COMPLETED NA

Examining How Motor Rehabilitation Promotes Brain Reorganization Following Stroke, an MRI Study

NCT01725919

COMPLETED NA

A Family-Based Diabetes Intervention for Hispanic Adults in an Emerging Community

NCT02114814

COMPLETED Phase 4

The Anesthetic Efficacy of 3% Mepivacaine Plus 2% Lidocaine With 1:100,000 Epinephrine for Lower Jaw Dental Injections

NCT01574807

COMPLETED

Nutritional Regulation of Wound Inflammation: Part II

NCT01618045

COMPLETED Phase 4

Testing the Anesthetic Effectiveness of Three Different Dental Local Anesthetics Injected Next to a Lower First Molar

NCT01567839

COMPLETED

Epigenomic Dysregulation in Preeclampsia-Associated Chronic Hypertension

NCT01682304

COMPLETED Phase 1

Inflammation, Polyphenols, and Genetics

NCT01568827

COMPLETED

Genetic Influences on Statin Blood Concentrations in African Americans

NCT01569867

COMPLETED NA

Robotic Brace Incorporating Electromyography for Moderate Affected Arm Impairment After Stroke

NCT01654315

COMPLETED Phase 2

Gastric Plication and Banding

NCT02072395

TERMINATED

Muscle Atrophy in Patients With Severe Sepsis

NCT01717651

COMPLETED NA

Patient Characteristics and Cognitive vs. Behavioral Therapies for Depression

NCT04529694

COMPLETED NA

Vitamin D and Sexual Health

NCT01450462

COMPLETED NA

Mothers in Motion Program to Prevent Weight Gain in WIC Mothers (MIM)

NCT01839708

COMPLETED NA

Provitamin A Absorption and Conversion With Avocados

NCT01432210

COMPLETED NA

Examining the Effects of Video-game Exercise on Mobility and Brain Plasticity in Individuals With Multiple Sclerosis

NCT01780792

COMPLETED NA

Comparison of Carotenoid Bioavailability From Fresh Papaya, Tomato and Carrot

NCT01748916

COMPLETED NA

A Systematic Oral Care Program in Post-Mechanically Ventilated, Post-Intensive Care Patients

NCT03886623

COMPLETED

Immunological Characterization of Blood of Normal Individuals

NCT01386892

COMPLETED NA

Use of an Electronic Medical Record in the Primary Care Setting to Improve Herpes Zoster Vaccination Rates

NCT01519570

COMPLETED Phase 1

Clinical Evaluation of Bioadhesive Gels for Oral Cancer Chemoprevention

NCT01192204

COMPLETED Phase 3

Comparing Desflurane to Sevoflurane for the Effect on Recovery Time in Patients Undergoing Urological Cystoscope Surgery

NCT01219881

COMPLETED NA

Mental Practice in Chronic, Stroke Induced Hemiparesis

NCT01651533

COMPLETED

Physiological Brain Atlas Development

NCT01210534

COMPLETED NA

Exercise Cardiac Magnetic Resonance Imaging Accuracy for Cardiovascular Stress Testing

NCT01592565

COMPLETED

Establishment of Biomarkers for Fabry Disease

NCT01165697

TERMINATED NA

Omega-3 Fatty Acid Supplements and Dry Eye

NCT01213342

COMPLETED

Impact of Xenazine(Tetrabenazine)on Gait and Functional Activity in Individuals With Huntington's Disease

NCT01451463

COMPLETED

Fractal Analysis of the Pulmonary Arterial Tree in Pulmonary Hypertension

NCT01135706

TERMINATED

Mechanism of Endothelial Dysfunction in Obstructive Sleep Apnea (OSA)

NCT01027078

← Previous Page 10 of 12 Next →

Phase Distribution

PhaseTrial count
Phase 1 35
Phase 2 25
Phase 3 5
Phase 4 34

What is open in the Ohio State University pipeline

117 recruiting of 552 indexed (21% open); 319 completed (58%).

Phase mix: 39 late (III/IV) vs 60 early (I/II) (early-phase heavy).

Top condition: Suicidal Ideation (8 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Ohio State University: open-pipeline peers nationwide

Peers matched on 552 registered trials and 21% open enrollment, not the therapeutic-area sidebar.

Ohio State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0200400600 5%10%15%20%25% Total trials Recruiting share Ohio State UniversityAmgenMerck Sharp & DohmeVirginia Commonwealth UniversityOregon Health and Science UniversityUniversity of LouisvilleMedical College of WisconsinNova Southeastern UniversityColorado State University
Ohio State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Ohio State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 552 trials (± recruiting share)

Sponsors near 21% open enrollment (± trial volume)

What to do with this Ohio State University page

552 registered trials is a research-attention snapshot, not an endorsement of Ohio State University or any single study.

  • 117 of Ohio State University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Suicidal Ideation is the condition Ohio State University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Suicidal Ideation trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Ohio State University pipeline card: 552 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.